1120 results about "Mannan" patented technology

Personal care compositions comprise (a) from about from about 5 wt. % to about 35 wt. % of a detersive surfactant; (b) at least about 0.05 wt. % of a galactomannan polymer derivative having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, the galactomannan polymer derivative selected from a cationic galactomannan polymer derivative and an amphoteric galactomannan polymer derivative having a net positive charge, the galactomannan polymer derivative having a molecular weight from about 1,000 to about 10,000,000 and a cationic charge density from about 0.9 meq / g to about 7 meq / g; and (c) at least about 20 wt. % of an aqueous carrier. Methods of treating hair or skin comprise applying the personal care composition as described above to the hair or skin and rinsing the hair or skin.

Shampoo compositions comprise (a) from about 5% to about 50% of one or more detersive surfactants; (b) a dispersed gel network phase comprising: (i) at least about 0.05% of one or more fatty amphiphiles; (ii) at least about 0.01% of one or more secondary surfactants; and (iii) water; (c) at least about 0.05% of a galactomannan polymer derivative with a net positive charge and having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, wherein the galactomannan polymer derivative has: (i) a molecular weight from about 1,000 to about 10,000,000; and (ii) a cationic charge density from about 0.7 meq / g to about 7 meq / g; and (d) at least about 20% of an aqueous carrier; all by weight of the shampoo composition.

The present invention relates to methods of producing and / or isolating MBL compositions. In particular the invention relates to methods of producing and / or isolating novel recombinant human MBL preparations with high similarity to natural human MBL. The MBL preparations may be used in compositions, medicaments and in methods for treatment of conditions such as those related to immunosuppressive conditions and / or to conditions of MBL deficiencies including latent conditions. Conditions of deficiencies of Mannan-Binding Lectin (MBL) are associated with increased susceptibility to infections.

Shampoo compositions comprise (a) from about 5% to about 50% of one or more detersive surfactants; (b) a dispersed gel network phase comprising: (i) at least about 0.05% of one or more fatty amphiphiles; (ii) at least about 0.01% of one or more secondary surfactants; and (iii) water; (c) at least about 0.05% of a galactomannan polymer derivative with a net positive charge and having a mannose to galactose ratio of greater than 2 : 1 on a monomer to monomer basis, wherein the galactomannan polymer derivative has: (i) a molecular weight from about 1,000 to about 10,000,000; and (ii) a cationic charge density from about 0.7 meq / g to about 7 meq / g; and (d) at least about 20% of an aqueous carrier; all by weight of the shampoo composition.

A hair conditioning composition comprising:a) from about 0.01 wt. % to about 10 wt. % of a non-guar galactomannan polymer derivative having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, said non-guar galactomannan polymer derivative selected from the group consisting of a cationic non-guar galactomannan polymer derivative and an amphoteric non-guar galactomannan polymer derivative having a net positive charge;i. wherein said non-guar galactomannan polymer derivative has a molecular weight from about 1,000 to about 10,000,000; andii. wherein said non-guar galactomannan polymer derivative has a cationic charge density from about 0.7 meq / g to about 7 meq / g;b) a conditioning agent selected from the group consisting of cationic surfactants, cationic polymers, nonvolatile silicones, nonvolatile hydrocarbons, saturated C14 to C22 straight chain fatty alcohols, nonvolatile hydrocarbon esters, and mixtures thereof; andc) wherein said hair conditioning composition is substantially free of an anionic surfactant.

The invention discloses probiotic type premix feed for laying hens, which is prepared from vitamin compound premix feed for the laying hens in laying period, a bacillus and lactobacilli compound preparation, xylan and mannan complex enzyme, phytase, methionine, lycine, choline chloride, common salt, calcium hydrophosphate, stone dust, fish meal, corn gluten meal, sodium bicarbonate, trace element compound premix feed for the laying hens in the laying period, ethoxyquinoline, bentonite, and rice chaff by mixing in proportion. Compared with the common compound feed for the laying hens, the compound feed prepared by the premix feed reduces discharge of harmful substances such as nitrogen and phosphorus in chicken manure by more than 20 percent, reduces the concentration of harmful gases such as ammonia in a hen house by more than 40 percent, improves the feed utilization rate by 5 to 10 percent and the laying rate by 3 to 5 percent, averagely prolongs the laying period by 25 days, and reduces feeding cost by 5 to 8 percent and the death-cull rate of the laying hens.

Isolated and / or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods of at least partially degrading, cleaving, or removing polysaccharides, lignocellulose, cellulose, hemicellulose, lignin, starch, chitin, polyhydroxybutyrate, heteroxylans, glycosides, xylan-, glucan-, galactan, or mannan-decorating groups using isolated and / or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius.

The invention belongs to the technical field of feed additives, and in particular relates to complex enzyme for a feed. The complex enzyme comprises 7,500 to 15,000U / g of xylanase, 1,000 to 3,000U / g of mannose, 50 to 80U / g of galactosidase, 200 to 700U / g of cellulose, 500 to 1,500U / g of beta-glucanase, 150 to 1,000U / g of alpha-amylase, 2,000 to 10,000U / g of protease and 100 to 200U / g of pectinase. By adding corresponding enzyme preparations, the anti-nutrition function of the complex enzyme is reduced, the feed utilization is improved, and the animal production efficiency is improved, so the problems that the utilization rate of animal feed raw materials is low and the animal production performance is inhibited are effectively solved; meanwhile, the complex enzyme has the advantages of reasonable raw material mixing, good effect, and low overall cost.

High-yielding method for chemical hydrolysis of lignocellulose into monosaccharides. The process of the invention can additionally be applied to cellulose, xylan and related biomass polysaccharides, such as galactan, mannan, or arabinan. The method is employed for hydrolysis of a biomass polysaccharide substrate. The process is carried out in an ionic liquid in which cellulose is soluble in the presence of catalytic acid at a temperature sufficiently high to initiate hydrolysis. Water is added to the reaction mixture after initiation of hydrolysis at a rate controlled to avoid precipitation yet avoid undesired sugar dehydration products such ad HMF. Hydrolysis product is useful as feedstock for fermentations including fermentation processes for ethanol, butanol and other fuels.

The invention discloses a method for producing a complex micro-ecological preparation with microbial agents and enzyme. According to the action principles and characteristics of every microbial strain, the method adopts scientific combination and adds enzyme preparations and acidifier to enable microorganisms in the product to grow rapidly and take dominance in fermented feed and animal bodies so as to reduce the growth opportunity of miscellaneous bacteria. The preparation comprises the following components: bacillus subtilis, lactobacillus plantarum, candida utilis yeast, lactobacillus acidophilus, protease, amylase, cellulase, xylanase, mannanase, galactosidase, pectinase and citric acid. As all strains of the product adopt liquid deep fermentation culture, the non-polluting property of the product is guaranteed. Liquid microbial agents ensure that the number of bacterial colonies of the product is more than 100 million and the product is free from the pollution of other miscellaneous bacteria, while solid microbial agents ensure that the number of bacterial colonies of the product is more than 1 billion and the proportion of miscellaneous bacteria to effective bacteria is not more than 0.0001. The preparation contains bacillus, lactic acid bacteria and yeast, can apply to the processes of making green-yellow storage feed, fermenting feed, soaking feed, and the like, can be directly added to feed for feeding, and can improve the growth performance of ruminant animals, poultry, pigs, aquatic products and special animals.

A genetically modified organism comprising: at least one nucleic acid sequence and / or at least one recombinant nucleic acid isolated from Alicyclobacillus acidocaldarius and encoding a polypeptide involved in at least partially degrading, cleaving, transporting, metabolizing, or removing polysaccharides, cellulose, lignocellulose, hemicellulose, lignin, starch, sugars, sugar oligomers, carbohydrates, complex carbohydrates, chitin, heteroxylans, glycosides, xylan-, glucan-, galactan, or mannan-decorating groups; and at least one nucleic acid sequence and / or at least one recombinant nucleic acid encoding a polypeptide involved in fermenting sugar molecules to a product. Additionally, enzymatic and / or proteinaceous extracts may be isolated from one or more genetically modified organisms. The extracts are utilized to convert biomass into a product. Further provided are methods of converting biomass into products comprising: placing the genetically modified organism and / or enzymatic extracts thereof in fluid contact with polysaccharides, cellulose, lignocellulose, hemicellulose, lignin, starch, sugars, sugar oligomers, carbohydrates, complex carbohydrates, chitin, heteroxylans, glycosides, and / or xylan-, glucan-, galactan, or mannan-decorating groups.

The invention relates to an early weaning meat sheep fattening compound biological feed additive, which belongs to the technical field of animals feeding by feed. The feed additive comprises prebiotics consisting of candida utilis, bacillus subtilis and a lactobacillus plantarum microbial agent, non-starch polysaccharide enzyme containing cellulase, xylanase, beta-dextranase, beta-mannase and pectinase and a yeast culture formed by using saccharomyces cerevisiae to completely ferment bean pulp. The additive is specially used for fattening period ration of the early weaning(the weaning lunar age is less than or equal to 2 ages of the moon) meat sheep, and the adding percentage for the full-mixing ration of the fast-fattening meat sheep in 3 to 5 ages of the moon is 1 percent. The additive can provide functional nutrients such as digestive enzyme, B group vitamins and growth promoting factors, and the like which are inadequately produced and insufficient for the early weaning baby sheep and simultaneously contains probiotics for adjusting the micro-ecological environment in intestinal canals, thereby improving the immunity and the healthy level of the baby meat sheep; and after weaning, the daily gaining in weight is more than 10 percent in the prior period and later period of fattening, and the economic benefits are obviously improved.

Disclosed is a substantially anhydrous, powdered, galactomannan composition consisting essentially of a galactomannan hydrocolloid exhibiting about 50% to about 90% by weight of anhydromannose residues and about 10% to about 50% by weight anhydrogalactose residues; less than about 1% by weight of protein material and less than about 3% of other nonaqueous impurities. This material is useful for preparing pharmaceutical compositions both in the substantially anhydrous form but preferably in an anhydrated form which includes about 5-15% by weight water. The pharmaceutical compositions comprise a therapeutically effective amount of a drug, the hydrated powered gallactomannan composition and optionally other pharmaceutically-acceptable excipients. When the hydrated powdered purified glactomannan of the invention is used to form a tablet, one sees improved hardness in the tablet formed. The pharmaceutical composition of the invention is particularly valuable for delivering a therapeutically effective drug to the colon without significant release of the drug in the upper GI tract after oral administration of the composition. Unique means to prepare the purified galactomannan in large quantities is provided.

The invention relates to the discovery and characterization of mannan binding lectin-associated serine protease-2 (MASP-2), a new serine protease that acts in the MBLectin complement fixation pathway.

Laundry detergent compositions comprising a mannanase and a cotton soil release polymer for superior cleaning and soil release performance.

The invention discloses a preparation method of high-purity mannan oligosaccharide. The preparation method comprises the steps of 1, producing a mannan oligosaccharide mixture through enzymolysis conversion; 2, carrying out centrifugal separation: separating enzymatic hydrolysate through a centrifugal machine; 3, carrying out ceramic membrane filtration: filtering centrifugate through a ceramic membrane group as precision separation to remove protein, starch and polysaccharide substances; 4, carrying out ion exchange refining: desalting, decoloring and deodorizing filtrate through a mannan oligosaccharide ceramic membrane; 5, carrying out 2000 molecular weight ultrafiltration: ultrafiltering ion exchange refining liquid through a polyether sulfone-polyamide composite membrane with interception as Dalton to obtain a polymerization degree; 6, carrying out nanofiltration: filtering sugar liquid through a ceramic membrane, ion exchange refining and an ultrafiltration membrane; and 7, carrying out spray drying: preheating a nano-filtered concentrated solution, and drying in a spray drying tower. The dried product contains more than 95% of mannan oligosaccharide, and has an obvious function of multiplying bifidobacterium; meanwhile, the product, as a most promising substitute, can reduce harmful bacteria.

The present invention provides an improved and more efficient method for the purification of Beta glucan, mannan and manno-protein complexes or immuno-potentiating substances, directly from yeast. In addition, the present invention provides methods for the production of Beta glucan, mannan and manno-proteins for use in animal feed to (1) prepare and enhance the immune system to fight infections more effectively and efficiently, (2) increase resistance to and decrease duration of bacterial and viral infections, (3) allow producers to reduce or remove “growth promotion antibiotics” in feed systems, thus producing more naturally grown animals, (4) reduce or prevent the negative growth response normally associated with administration of live vaccines to animals and (4) other associated health benefits such as in the case of swine of increased piglet litter size and survivability for piglets after weaning when Sows fed this novel Beta glucan extract.

The invention discloses a complex enzyme preparation for a growing and fattening pig feed. The complex enzyme preparation for the growing and fattening pig feed comprises the following eight enzymes: acid protease, amylase, beta-mannase, xylanase, beta-dextranase, cellulase, pectinase and phytase; and the enzyme activity ratio of the eight enzymes is sequentially 1: (0.8-14.5): (0.19-0.3): (33.7-35): (25-30): (3.2-3.5): (0.19-2.0): (0-0.025). The complex enzyme preparation can degrade various anti-nutritional factors in the feed, reduce the chime viscosity of the intestinal tract, improve the metabolic energy of the feed, improve the digestion rate of growing and fattening pigs on protein and starch, reduce the nutrient content of the chime entering the intestinal tract, effectively inhibit the reproduction of harmful microbes in the intestinal tract, reconcile the micro-ecological balance of the intestinal tract, promote the health of the pigs, improve the average daily gain of the growing and fattening pigs, reduce the feed-meat ratio, shorten the maintenance period and improve the economic benefit.

The invention relates to enzymes having xylanase, mannanase and / or glucanase activity, e.g., catalyzing hydrolysis of internal β-1,4-xylosidic linkages or endo-β-1,4-glucanase linkages; and / or degrading a linear polysaccharide beta-1,4-xylan into xylose. Thus, the invention provides methods and processes for breaking down hemicellulose, which is a major component of the cell wall of plants, including methods and processes for hydrolyzing hemicelluloses in any plant or wood or wood product, wood waste, paper pulp, paper product or paper waste or byproduct. In addition, methods of designing new xylanases, mannanases and / or glucanases and methods of use thereof are also provided. The xylanases, mannanases and / or glucanases have increased activity and stability at increased pH and temperature.

The invention relates to bio-enzyme gel breaker, in particular to formula and technique for gel breaking of water-based guargum fracturing fluid by using the bio-enzyme gel breaker. The bio-enzyme gel breaker contains the following components in percentage by weight: 10-50% of beta- mannose, 0-20% of cellulose, 0-10% of pectinase, 0-15% of glucanase, 0-10% of xanthase, 3-10% of (NH4)2SO4, 2-5% of NaCl, 1.5-5% of ZnCL2 and 0-60% of persulfate. The fracturing fluid gel breaking technique comprises the following steps: dissolving the bio-enzyme gel breaker in borax crosslinked fluid; mixing and blending the crosslinked fluid and the guargum base fluid, crosslinking, forming jelly, and then mixing with proppant, pressing the mixture into the oil-water well until the mixture enters the fractured crack. In this way, the fracturing process is finished. The bio-enzyme gel breaker degrades the macromolecular guargum in the stratum fracturing fluid into small micromolecular sugar, and when the jelly breaks up, the proppant is left underground, the fracturing gel breaking fluid flows back, and in this way, the construction can be completed. The bio-enzyme gel breaker has good gel breaking performance, the construction process is reasonable, the viscosity of the fracturing fluid can not decrease too early, the gel of the fracturing fluid can be broken evenly and thoroughly with little residue and small harm to the stratum, and the operation is simple and convenient.

Described are a number of compositions, namely a konjac mannan mixture, a ginseng composition, and a composition comprising konjac mannan and American ginseng. Methods of use of these compositions are described including their use for reducing blood glucose in non-diabetic and diabetic individuals, as well as reducing postprandial blood glucose in such individuals. Applications in the treatment of hyperlipidemia, high blood pressure, an increase in nitric oxide, Syndrome X and cardiovascular disease are also described. Various other applications of the compositions and methods are also described.

The present invention is directed to novel compositions of bio-active compounds comprising 4-hydroxyisoleucine and one or more compounds selected from the group of amino acids, alkaloids, glycosides, volatile oils, saponins, sapogenins, mannans, flavonoids, fatty acids, vitamins and provitamins, minerals, and carbohydrates. Preferably, the novel compositions of bio-active compounds include 4-hydroxyisoleucine and one or more amino acids selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, proline, lysine, histidine, and gamma-aminobutyrate. The composition of bio-active compounds preferably include between about ten percent and about seventy percent of 4-hydroxyisoleucine and between about twenty percent and about forty percent of other amino acids. The bio-active compounds of the novel composition of the present invention may be derived, isolated, and / or extracted from Fenugreek seeds. A preferred method for extracting the bio-active compounds from Fenugreek seeds includes the steps of: (1) providing a plurality of Fenugreek seeds; (2) preparing the Fenugreek seeds; and (3) extracting a novel composition of bio-active compounds from the Fenugreek seeds, which include a preliminary extraction step and a secondary extraction step. The compositions of bio-active compounds have been found to be helpful in restoring healthy energy balance in humans and animals, aiding in weight management efforts, and for balancing blood sugar levels by way of assisting the body to make more efficient use of existing (i.e., endogenous) insulin.

The present invention relates to pharmaceutical compositions comprising MBL and / or MBL variants. In particular the invention relates to pharmaceutical compositions comprising at least 200 μg / ml protein containing material, wherein mannan binding lectin (MBL) and / or MBL variants constitutes at least 35% (w / w) of the total protein; or to compositions comprising at least 400 μg / ml mannan binding lectin (MBL) and / or MBL variants. In addition the invention relates to pharmaceutical compositions comprising MBL and / or MBL variants and divalent cations. The invention also describes methods of preparing said compositions.The pharmaceutical compositions according to the invention may for example be used in methods of treatment of a number of different clinical conditions including infections. Uses of the compositions for preparation of medicaments for treatment of a clinical condition are also described.

The present invention relates to substantially pure mannan-binding lectin associated serine protease-2 (MASP-2) polypeptides and fragments thereof as well as nucleic acids encoding such polpeptides. Furthermore, the present invention relates to uses of a substantially pure polypeptide comprising amino acid sequences derived from mannan-binding lectin associated serine protease-2 (MASP2) or a functional homologue thereof for the production of a pharmaceutical composition as well as pharmaceutical compositions comprising MASP-2 and / or MASP-2 fragments. In addition the present invention relates to inhibitors of MASP-2 and pharmaceutical compositions comparing such inhibitors. Methods for detecting MASP-2 nucleic acid expression are included in the invention.

The invention discloses a method for breeding Bama miniature pigs. The method includes the steps that pregnant sows are fed by postconceptual age fetus growth fodder from the 92 day of pregnancy to the day of farrowing, and the postconceptual age fetus growth fodder comprises, by weight, 40-70 parts of corn, 10-30 parts of rice bran, 25-40 parts of black bean pulp, 10-20 parts of fish protein concentrate, 15-25 parts of sweet potato leaves, 30-50 parts of hair weeds, 0.5-5 parts of rhizoma atractylodis macrocephalae, 0.5-5 parts of radix scutellariae, 3-8 parts of massa medicata fermentata, 5-10 parts of radix salviae miltiorrhizae, 5-10 parts of rhamnus aurea and 0.5-2 parts of plant extract, wherein the plant extract is a water solution containing 3% of cinnamyl aldehyde, 4% of mannan oligosaccharide and 5% of carvacrol. According to the method for breeding the Bama miniature pigs, the growth activity of piglets and the reproductive performance of the sows after farrowing can be improved obviously, and the healthy growth of the Bama miniature pigs at the later period can be promoted.

The invention relates to polypeptides having glucanase, e.g., endoglucanase, mannanase, xylanase activity or a combination of these activities, and polynucleotides encoding them. In one aspect, the glucanase activity is an endoglucanase activity (e.g., endo-1,4-beta-D-glucan 4-glucano hydrolase activity) and comprises hydrolysis of 1,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (e.g., carboxy methyl cellulose and hydroxy ethyl cellulose) lichenin, beta-1,4 bonds in mixed beta-1,3 glucans, such as cereal beta-D-glucans or xyloglucans and other plant material containing cellulosic parts. In addition, methods of designing new enzymes and methods of use thereof are also provided. In alternative aspects, the new glucanases e.g., endoglucanases, mannanases, xylanases have increased activity and stability, including thermotolerance or thermostability, at increased or decreased pHs and temperatures.

The invention discloses a compound enzyme preparation for ramie degumming, and a preparation method thereof. The method comprises the steps of taking bacillus cereus obtained through separation as an original strain, preparing high-enzyme-activity alkaline pectinase which contains glucanase and neutral protease through seed culture and liquid-submerged fermentation, and compounding an appropriate amount of xylanase and mannanase on the basis of the alkaline pectinase so as to prepare the compound enzyme preparation. The invention also discloses a ramie degumming process, and the compound enzyme preparation is applied to an enzyme refining step in the ramie degumming process. The process enables the alkaline pectinase and hemicellulase to play a role jointly by compounding a plurality of biological enzymes, so as to achieve the aim of degumming. The process can save acid-base raw materials, and has the advantages of mild treatment conditions, low cost, good fiber quality, little pollution on environment and the like.

The invention discloses a special compound feed for crabs. The compound feed consists of soybean meal, rapeseed meal, peanut meal, corn protein powder, spray-dried animal blood cells, fish meal, shrimp meal, four, fish dissolving-pulp protein powder, yeast extract, fish oil, soybean lecithin oil, bentonite, monocalcium phosphate, a mildew preventive, mannan oligosaccharide, glycine betaine, a hulling element, methionine, choline, perilla seed extract, a vitamin premix and a mineral premix. The raw materials of the compound feed are stable in source, high in utilization ratio, balanced in nutrient content and relatively low in cost. The preferred fish dissolving-pulp protein powder enhances the feed attraction of the feed. An advanced puffing process is adopted so as to further improve the utilization ratio and water resistance of the feed and reduce waste and water pollution. Meanwhile, an immune nutrition additive is adopted so as to significantly enhance the immune function and anti-stress capacity of the crabs and significantly increase the survival rate. The compound feed is much greener and more environmentally friendly, and efficiency increase is particularly significant in a high-density river crab breeding mode.